Fatemeh Ramezani

1.4k total citations · 1 hit paper
24 papers, 917 citations indexed

About

Fatemeh Ramezani is a scholar working on Molecular Biology, Biomaterials and Nutrition and Dietetics. According to data from OpenAlex, Fatemeh Ramezani has authored 24 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Biomaterials and 5 papers in Nutrition and Dietetics. Recurrent topics in Fatemeh Ramezani's work include Nanoparticle-Based Drug Delivery (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and RNA Interference and Gene Delivery (5 papers). Fatemeh Ramezani is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and RNA Interference and Gene Delivery (5 papers). Fatemeh Ramezani collaborates with scholars based in Iran, Canada and Türkiye. Fatemeh Ramezani's co-authors include Mehdi Sabzichi, Hamed Hamishehkar, Nasser Samadi, Ommoleila Molavi, Marjan Ghorbani, Zeinab Ghesmati, Behzad Baradaran, Mohammad Reza Sadeghi, Houman Kahroba and Hamid Maadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Fatemeh Ramezani

24 papers receiving 902 citations

Hit Papers

Up-down regulation of HIF... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Up-down regulation of HIF-1α in cancer progression
    2021 190 citations Behzad Baradaran, Ommoleila Molavi et al. Gene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemeh Ramezani Iran 16 449 171 168 109 88 24 917
Mehdi Sabzichi Iran 14 406 0.9× 150 0.9× 165 1.0× 86 0.8× 101 1.1× 18 815
Huiyun Zhang China 18 430 1.0× 190 1.1× 67 0.4× 114 1.0× 87 1.0× 57 983
Rebecca L. Bigelow United States 11 541 1.2× 146 0.9× 145 0.9× 87 0.8× 225 2.6× 12 1.3k
Ji Eun Won South Korea 19 494 1.1× 128 0.7× 93 0.6× 110 1.0× 84 1.0× 37 932
Behrad Darvishi Iran 21 490 1.1× 223 1.3× 120 0.7× 171 1.6× 205 2.3× 41 1.2k
Gamze Güney Eskiler Türkiye 20 445 1.0× 183 1.1× 107 0.6× 161 1.5× 220 2.5× 92 984
Rosalba Minelli Italy 19 478 1.1× 146 0.9× 118 0.7× 88 0.8× 178 2.0× 33 1.0k
Sabrina Margarucci Italy 15 482 1.1× 79 0.5× 228 1.4× 99 0.9× 71 0.8× 27 1.1k
Ebrahim Rahmani Moghadam Iran 13 568 1.3× 107 0.6× 319 1.9× 94 0.9× 170 1.9× 18 946
T. R. Santhosh Kumar India 19 484 1.1× 101 0.6× 99 0.6× 75 0.7× 135 1.5× 40 992

Countries citing papers authored by Fatemeh Ramezani

Since Specialization
Citations

This map shows the geographic impact of Fatemeh Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Ramezani more than expected).

Fields of papers citing papers by Fatemeh Ramezani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Ramezani. The network helps show where Fatemeh Ramezani may publish in the future.

Co-authorship network of co-authors of Fatemeh Ramezani

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Ramezani. A scholar is included among the top collaborators of Fatemeh Ramezani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Ramezani. Fatemeh Ramezani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shafiee, Sayed Mohammad, Fatemeh Ramezani, Omid Vakili, et al.. (2024). NRF-mediated autophagy and UPR: Exploring new avenues to overcome cancer chemo-resistance. European Journal of Pharmacology. 988. 177210–177210. 3 indexed citations
2.
3.
Marjani, Ahmad Poursattar, et al.. (2024). Dual pH/redox-responsive size-switchable polymeric nano-carrier system for tumor microenvironment DTX release. Journal of Biomaterials Science Polymer Edition. 35(14). 2220–2249. 1 indexed citations
4.
Marjani, Ahmad Poursattar, et al.. (2023). pH/redox responsive size‐switchable intelligent nanovehicle for tumor microenvironment targeted DOX release. Scientific Reports. 13(1). 22475–22475. 18 indexed citations
5.
Baradaran, Behzad, et al.. (2021). Up-down regulation of HIF-1α in cancer progression. Gene. 798. 145796–145796. 190 indexed citations breakdown →
6.
Sabzichi, Mehdi, Mohsen Rashidi, Jamal Mohammadian, et al.. (2021). Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(7). 1521–1528. 16 indexed citations
7.
8.
Maroufi, Nazila Fathi, et al.. (2019). Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line. Nutrition and Cancer. 72(4). 653–661. 16 indexed citations
9.
Jamali, Navid, Zohreh Mostafavi‐Pour, Fatemeh Zal, et al.. (2019). Combination Effect of Caffeine and Caffeic Acid Treatment on the Oxidant Status of Ectopic Endometrial Cells Separated from Patients with Endometriosis.. SHILAP Revista de lepidopterología. 44(4). 315–324. 16 indexed citations
10.
Raeisi, Sina, et al.. (2019). Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line. Process Biochemistry. 83. 168–175. 56 indexed citations
11.
Ghorbani, Marjan, et al.. (2018). Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells. Journal of Drug Delivery Science and Technology. 49. 268–276. 72 indexed citations
12.
Mokarram, Pooneh, et al.. (2018). Derivative of Stevioside; CPUK02; Restores ESR1 Gene Methylation in MDA-MB 231. Asian Pacific Journal of Cancer Prevention. 19(8). 2117–2123. 1 indexed citations
13.
Sabzichi, Mehdi, et al.. (2017). Fabrication of all-trans-retinoic acid-loaded biocompatible precirol: A strategy for escaping dose-dependent side effects of doxorubicin. Colloids and Surfaces B Biointerfaces. 159. 620–628. 36 indexed citations
14.
Sabzichi, Mehdi, et al.. (2016). Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Molecular Biology Reports. 43(2). 99–105. 103 indexed citations
15.
Sabzichi, Mehdi, et al.. (2016). Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer. Journal of Microencapsulation. 33(4). 372–380. 73 indexed citations
16.
Salehi, Roya, Abolfazl Akbarzadeh, Nasser Samadi, et al.. (2015). Biocompatible Polymer Coated Paramagnetic Nanoparticles for Doxorubicin Delivery: Synthesis and Anticancer Effects Against Human Breast Cancer Cells. International Journal of Polymeric Materials. 64(14). 718–726. 14 indexed citations
17.
Sabzichi, Mehdi, Hamed Hamishehkar, Fatemeh Ramezani, et al.. (2014). Luteolin-loaded Phytosomes Sensitize Human Breast Carcinoma MDA-MB 231 Cells to Doxorubicin by Suppressing Nrf2 Mediated Signalling. Asian Pacific Journal of Cancer Prevention. 15(13). 5311–5316. 94 indexed citations
18.
Ramezani, Fatemeh, et al.. (2012). CpG Island Methylation Profile of Estrogen Receptor Alpha in Iranian Females with Triple Negative or Non-triple Negative Breast Cancer: New Marker of Poor Prognosis. Asian Pacific Journal of Cancer Prevention. 13(2). 451–457. 14 indexed citations
19.
Salami, Siamak, et al.. (2011). Impact of triple negative phenotype on prognosis and early onset of breast cancer in Iranian females.. PubMed. 12(3). 719–24. 8 indexed citations
20.
Salami, Siamak, et al.. (2011). Allelic frequency and genotypes of prion protein at codon 136 and 171 in Iranian Ghezel sheep breeds. Prion. 5(3). 228–231. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Sabzichi Breakdown of academic impact, for papers by Huiyun Zhang Breakdown of academic impact, for papers by Rebecca L. Bigelow Breakdown of academic impact, for papers by Ji Eun Won Breakdown of academic impact, for papers by Behrad Darvishi Breakdown of academic impact, for papers by Gamze Güney Eskiler Breakdown of academic impact, for papers by Rosalba Minelli Breakdown of academic impact, for papers by Sabrina Margarucci Breakdown of academic impact, for papers by Ebrahim Rahmani Moghadam Breakdown of academic impact, for papers by T. R. Santhosh Kumar
Rankless by CCL
2026